Detailed price information for Eledon Pharmaceuticals Inc (ELDN-Q) from The Globe and Mail including charting and trades.

A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. | A phase 2a trial of NMD ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte ...

A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing ...

Leveraging human organoid-based mechanistic investigation, researchers reveal how an immunosuppressive drug, antithymocyte ...

Researchers at University of Tsukuba have discovered that an immunosuppressive drug affects microglia, the resident immune ...

DipCoin today announced the official launch of its Season 1: Horizon Points & Referral System, marking the activation of ...

The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic ...

Healthy adults trained to upregulate reward circuitry using neurofeedback showed stronger immune responses to HBV vaccination ...

For individuals struggling to find relief from chronic joint and muscle pain, Synergy Spine & Performance is now featuring ...

Lindsey Vonn’s viral workout video after tearing her ACL drew a stunned reaction from a sports doctor as she eyes the 2026 ...